| Trial name or title |
Safety, Tolerability, Immunological and Clinical Efficacy of Multiple Subcutaneous Doses of DiaPep277 in Latent Autoimmune Diabetes in Adults (LADA) |
| Methods |
Randomised controlled trial |
| Participants |
Diabetes according to WHO criteria, duration 2 month to 5 years, diabetes controlled by diet and insulin for 2 or more weeks, aged 30 to 65, positive for GAD autoantibodies, fasting C‐peptide of 0.3 nmol/L or greater at screening |
| Interventions |
DiaPep277 compared to placebo |
| Outcomes |
Undefined |
| Starting date |
October 2002 |
| Contact information |
Jerry P Palmer University of Washington. |
| Notes |
|
